APP and Alzheimer disease: The amyloidogenic pathway favors loss of function APP with sequential cleavage of APP by β-secretase (BACE1) resulting in neurotoxic amyloid-β (Aβ) peptides 40 and 42, the major components of cerebral amyloid plaques associated with brain atrophy found in AD.